US Stock MarketDetailed Quotes

IKT Inhibikase Therapeutics

Watchlist
  • 2.2000
  • -0.0700-3.08%
Close Mar 4 16:00 ET
159.90MMarket Cap-0.71P/E (TTM)

About Inhibikase Therapeutics Company

Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in developing protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.

Company Profile

SymbolIKT
Company NameInhibikase Therapeutics
Listing DateDec 23, 2020
Issue Price10.00
Founded2008
CEOMr. Mark T. Iwicki
MarketNASDAQ
Employees14
Fiscal Year Ends12-31
Address3350 Riverwood Parkway South East,Suite 1900
CityAtlanta
ProvinceGeorgia
CountryUnited States of America
Zip Code30339
Phone1-678-392-3419
Websitehttp://www.inhibikase.com

Company Executives

  • Name
  • Position
  • Salary
  • Mark T. Iwicki
  • Director and Chief Executive Officer
  • --
  • Garth Lees-Rolfe
  • Vice President, Finance and Chief Financial Officer
  • --
  • Dr. John Ada PhD
  • Chief Scientific Officer
  • --
  • Dr. Christopher Cabell, F.A.C.C.,M.D.,M.H.S.
  • President and Head, Research and Development
  • --
  • Amit D. Munshi
  • Chairman of Board
  • --
  • Arvind Kush
  • Director
  • --
  • Vincent E. Aurentz
  • Director
  • --
  • Roberto Bellini
  • Director
  • --
  • David Canner
  • Director
  • --
  • Dr. Roy Freeman, M.D.
  • Independent Director
  • 65.85K
  • Dennis N. Berman
  • Independent Director
  • 74.85K
  • Dr. Terence A. Kelly, PhD
  • Medicinal Chemistry and Drug Discovery Consultant
  • --
  • Dr. Surendra Singh, PhD
  • Head of Chemistry, Manufacturing and Controls
  • --
  • Warren Olanow
  • Lead Medical Professional
  • --
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Bit Origin
BTOG
+12.12%
Strategy
MSTR
+9.66%
Bit Digital
BTBT
+4.35%
Bitfarms
BITF
+3.64%
Canaan
CAN
+3.39%

Unlock the Full List